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Objectives. The purposes of this study were to evaluate the
atrial electrophysiology and autonomic nervous system in patients
who had paroxysmal supraventricular tachycardia (PSVT) asso-
ciated with paroxysmal atrial fibrillation (PAF).
Background. PAF frequently appeared in patients with PSVT.
However, the critical determinants for the occurrence of PAF were
not clear.
Methods. This study population consisted of 50 patients who
had PSVT with (n 5 23) and without (n 5 27) PAF. Atrial
pressure, atrial size, atrial effective refractory periods (AERPs),
and AERP dispersion were evaluated during baseline and PSVT,
respectively. Twenty-four hour heart rate variability and barore-
flex sensitivity (BRS) were also examined.
Results. There was greater baseline AERP dispersion in pa-
tients with PAF than in those without PAF. The atrial pressure,
atrial size, AERPs in the right posterolateral atrium and distal
coronary sinus, and AERP dispersion were increased during
PSVT as compared with those during baseline. Patients with PAF
had greater AERP dispersion than those without PAF during
PSVT. The differences of atrial size, right posterolateral AERP,
and AERP dispersion between baseline and PSVT were greater in
patients with PAF than in those without PAF. BRS, but not heart
rate variability, was higher in patients with PAF than in those
without PAF. Univariate analysis showed that higher BRS (>4.5
ms/mm Hg, p 5 0.0002, odds ratio 5 16.1), AERP dispersion
during PSVT (>40 ms, p 5 0.0008, odds ratio 5 9.7), and increase
of right atrial area during PSVT (>2 cm2, p 5 0.016, odds ratio 5
10.7) were significantly correlated with the occurrence of PAF in
patients with PSVT.
Conclusions. Disturbed atrial electrophysiology and higher
vagal reflex could play important roles in the genesis of PAF in
patients with PSVT.
(J Am Coll Cardiol 1998;32:732–8)
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Paroxysmal atrial fibrillation (PAF) frequently occurred in
patients with paroxysmal supraventricular tachycardia (PSVT)
(1–4). However, the mechanisms responsible for the occur-
rence of PAF were not fully understood. Although previous
studies have suggested that atrioventricular (AV) accessory
pathway or slow AV node pathway itself may play an important
role in the genesis of PAF (5–11), disturbed atrial electrophys-
iology during PSVT may be the other mechanism of initiation
of PAF (1,5,6,12). Klein et al. (13) have shown increased atrial
refractoriness during PSVT and considered mechanoelectrical
feedback a cause of PAF during PSVT. Satoh et al. (14)
demonstrated that increasing atrial dispersion from atrial
stretch in canine heart could induce atrial fibrillation (AF). In
humen, increase of atrial size correlates well with an increased
vulnerability to AF (15). Thus, possible alteration of atrial size
and atrial pressure during PSVT may change the atrial elec-
trophysiologic properties and result in the occurrence of PAF.
Another possible mechanism is that autonomic nervous system
may be related to the genesis of PAF during PSVT. Although
Coumel et al. (16) have described different types of PAF
resulting from increased vagal tone or increased adrenergic
tone, there is no report about the role of autonomic nervous
system in patients who have PSVT associated with PAF.
Therefore, the purposes of this study were 1) to evaluate
the baseline atrial pressure, atrial size and atrial electrophysi-
ologic characteristics and to evaluate these changes during
PSVT in patients with and without PAF; 2) to investigate the
role of the autonomic nervous system in the occurrence of PAF
in these patients; 3) to study the critical determinant of the
occurrence of PAF in the patients with PSVT.
Methods
Patients characteristics. This study included 50 patients
who had PSVT and were divided into two groups. Group I
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included 23 patients (12 men and 11 women with a mean age
of 45 6 4 years) who had clinically documented PAF whereas
the episodes of PAF always preceded by PSVT. In 9 of these
patients, transition of PSVT into PAF was demonstrated by an
electrocardiogram. Group II included 27 patients (14 men and
13 women with a mean age of 43 6 4 years) who did not have
a history of PAF. None of these patients had other cardiovas-
cular diseases.
Baseline electrophysiologic study. As described previously
(17,18), each patient underwent a baseline electrophysiologic
study in the fasting, unsedated state for at least five half-lives
after discontinuation of antiarrhythmic drugs. Informed con-
sent for the study and ablation was obtained from each patient.
Four multipolar, closely spaced electrode catheters (interelec-
trode space 5 2 mm, Boston Scientific, MA) were introduced
from the right and left femoral veins and placed in the high
right atrium, low right posterolateral atrium, His bundle area
and right ventricle for programmed electrical stimulation and
recording. One steerable decapolar catheter (2-5-2-5-2-5-2
configuration, Daig) was introduced from the right internal
jugular vein and placed in the coronary sinus. Intracardiac
electrograms were displayed simultaneously with electrocar-
diographic leads I, II and VI on a multichannel oscilloscopic
recorder (MIDAS system series 2000) and were recorded on
paper at a speed of 100 to 150 mm/s. A programmed digital
stimulator (DTU-210 or 215, Bloom Associates Ltd., Reading)
was used for atrial and ventricular incremental pacing and
extrastimulation to induce tachycardia. The patients who
needed isoproterenol or atropine to induce tachycardia were
not included in this study.
Study protocol. After PSVT was initiated and sustained for
5 min, we measured hemodynamic parameters (mean blood
pressure, right atrial pressure, and pulmonary wedge pressure),
bilateral atrial size, AERPs, and stimulation thresholds. The
data of baseline study were obtained again from the same
parameters measured during sinus rhythm after PSVT termi-
nated more than 10 min.
1) Measurements of hemodynamic parameters. The right
atrial pressure and pulmonary wedge pressure were measured
by using the fluid-filled luminal catheter. The patient’s mean
blood pressure was measured by using intraarterial catheters
from femoral artery.
2) Measurement of AERP. The AERP and stimulation
threshold in high right lateral atrium, low right posterolateral
atrium, and distal coronary sinus were measured during PSVT
and during baseline study, respectively. Measurement of the
AERPs was made from an atrial extrastimulus (2 ms pulse
duration, twice threshold) introduced from early diastole after
every eighth atrial beat (during PSVT or during atrial pacing
with a rate similar to that of PSVT) until atrial capture
occurred twice in succession (in 2 ms increments). The mea-
sured AERPs were acceptable for analysis only if these data
were identical during two repeated measurements. AERP
dispersion was defined as the maximal difference of AERPs at
the three stimulation sites. Atrial vulnerability was defined as
the inducibility of PAF sustained more than 30 s from single
atrial extrastimulus during PSVT or during baseline study (a
basic atrial pacing cycle length similar to that during PSVT).
The patients with PAF sustained more than 10 min would
receive electrical cardioversion to restore to sinus rhythm. If
PAF was induced during the study protocol, repeated testing
was performed 15 min after PAF was spontaneously or elec-
trically converted to sinus rhythm.
3) Measurement of atrial size. Left atrial size and right atrial
size were measured at end systole by two-dimensional echo-
cardiography (Hewlett-Packard Sonus 1000 ultrasound sys-
tem) in the apical four chamber view (19).
4) Baroreflex sensitivity study. Baroreflex sensitivity study
(BRS) was determined only when the patients had stable heart
rate and blood pressure by using intravenous phenylephrine
after the baseline electrophysiologic study. Patients were
placed in supine position and were instructed to breathe
regularly. Continuous arterial pressure and surface electrocar-
diogram were recorded simultaneously at a paper speed of
25 mm/s. The blood pressure was increased by 15 to 30 mm Hg
by intravenous injection of phenylephrine (2–4 mg/kg body
weight). The dose found by this procedure was repeated at
least twice. Beat-by-beat changes in baseline systolic blood
pressure (in mm Hg) and in the lengths of the RR intervals (in
milliseconds) was calculated from records. Each RR interval
was plotted against the preceding arterial pressure pulse, and
linear regression analysis was performed. Only regression lines
exhibiting a significant correlation coefficient (p , 0.05) were
accepted for analysis. The final slope represents the mean
value of three or more successive determinations.
5) Heart rate variability study. The 24-h electrocardio-
graphic recordings were performed on the day before electro-
physiologic study. Tape-recorded electrocardiograms for each
subject were digitally processed and annotated by manual
editing with a Holter Analysis System (Oxford Medilog Excel,
Oxford Med. Instruments). After QRS configuration classifi-
cation, the longest and the shortest RR intervals on the RR
interval histogram, and the largest and the smallest RR ratios
on the RR ratio histogram were manually confirmed until no
QRS complex was mislabeled as either an artifact or an ectopic
beat. In this laboratory, time domain variables considered in
this study were mean RR interval (the mean of all coupling
intervals between normal sinus beats expressed in millisec-
onds), SDNN (the standard deviation of the mean RR interval
expressed in milliseconds), rMSSD (the root mean square of
differences of successive RR intervals), and PNN50 (the per-
centage of adjacent RR intervals that differed by more than
50 ms). In addition, three frequency-domain measurements,
Abbreviations and Acronyms
AERP 5 atrial effective refractory period
AV 5 atrioventricular
BRS 5 baroreflex sensitivity
PAF 5 paroxysmal atrial fibrillation
PSVT 5 paroxysmal supraventricular tachycardia
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namely, low-frequency component (0.04 to 0.15 Hz), high
frequency component (0.15 to 0.40 Hz), and low/high fre-
quency ratio were computed.
Statistical analysis. All data are expressed as mean 6
SEM. Comparisons of the data measured during PSVT and
baseline study were analyzed by paired t test for numerical
data. The differences of the measured numerical data between
different groups were analyzed by unpaired t test. Chi-square
test with Yates’ correction or Fisher exact test were used for
the categorical data. Univariate and multivariate analysis was
used to analyze the variables (tachycardia cycle length, hemo-
dynamics, atrial size, AERPs, AERP dispersion, BRS, and
heart rate variability) which could predict the occurrence of
PAF in patients with PSVT. A p value less than 0.05 was
considered to be statistically significant.
Results
Baseline study. In Group I (with PAF), there were 10
patients who had AV nodal reentrant tachycardia and 13
patients who had concealed accessory pathways associated with
AV reentrant tachycardia. In Group II (without PAF), there
were 15 patients who had AV nodal reentrant tachycardia and
12 patients who had concealed accessory pathways associated
with AV reentrant tachycardia. The age (45 6 4, versus 43 6
3 years, p . 0.05) and sex ratio (M/F, 12/11 versus 14/13, p .
0.05) were similar between Group I and Group II. The mean
blood pressure, mean right atrial pressure, pulmonary capillary
wedge pressure, and bilateral atrial size were also similar
between Group I and Group II (Table 1). Moreover, AERPs
and stimulation thresholds in the high right atrium, right
posterolateral atrium, and distal coronary sinus were also
similar between the two groups. However, AERP dispersion
was higher in Group I than in Group II (31 6 3 versus 22 6
2 ms, p , 0.05). Furthermore, atrial vulnerability was higher in
Group I (6 of 23, 26%) than in Group II (1 of 27, 4%, p ,
0.05).
During SVT. The tachycardia cycle lengths were similar
between Group I and Group II (329 6 8 versus 336 6 7 ms,
p . 0.05). The mean blood pressure, mean right atrial pres-
sure, pulmonary capillary wedge pressure and bilateral atrial
size were similar between Group I and Group II (Table 2). The
AERPs and stimulation thresholds in high right atrium, right
posterolateral atrium and distal coronary sinus were similar
between the two groups. However, AERP dispersion was
greater in Group I than in Group II (47 6 3 versus 31 6 2 ms,
p , 0.0001). Furthermore, atrial vulnerability was significantly
higher in Group I (19 of 23, 83%) than in Group II (3 of 27,
11%, p , 0.0001).
Baseline study versus PSVT. As compared with those dur-
ing baseline study, Group I and Group II patients had lower mean
systolic blood pressure (Group I, 101 6 3 vs 95 6 3 mm Hg, p ,
0.05, Group II, 103 6 3 vs 98 6 3 mm Hg, p , 0.05), higher mean
right atrial pressure (Group I, 3.2 6 0.6 vs 8.2 6 0.7 mm Hg, p ,
0.01, Group II, 3.4 6 0.5 vs 7.5 6 0.8 mm Hg, p , 0.01), higher
pulmonary capillary wedge pressure (Group I, 9.9 6 0.9 vs 21.6 6
1.2 mm Hg, p , 0.01, Group II, 9.4 6 0.8 vs 18.5 6 1.0 mm Hg,
p , 0.01), and greater atrial size (left or right) during PSVT (Fig.
1). The high right AERP during baseline study was similar to that
during PSVT; however, the AERPs in the right posterolateral
atrium and distal coronary sinus were longer during PSVT (Fig.
2). The stimulation thresholds in the high right atrium (Group I,
0.78 6 0.05 vs 0.66 6 0.05 mV, p , 0.05, Group II, 0.72 6 0.04
vs 0.64 6 0.04 mV, p , 0.05), right posterolateral atrium (Group
I, 0.72 6 0.05 vs 0.63 6 0.03 mV, p , 0.05, Group II, 0.70 6 0.04
vs 0.61 6 0.03 mV, p , 0.05), and distal coronary sinus (Group I,
0.90 6 0.07 vs 0.75 6 0.05 mV, p , 0.05, Group II, 0.88 6 0.05
Table 1. Hemodynamics, Atrial Size, Electrophysiologic
Characteristics During Baseline Study
Group I II p value
Age (yr) 45 6 3 43 6 3 NS
Sex (M/F) 12/11 14/13 NS
MBP (mm Hg) 101 6 3 103 6 3 NS
MRAP (mm Hg) 3.2 6 0.6 3.4 6 0.5 NS
PCWP (mm Hg) 9.9 6 0.9 9.4 6 0.8 NS
RAA (cm2) 11.0 6 0.5 11.3 6 0.4 NS
LAA (cm2) 10.6 6 0.5 10.9 6 0.5 NS
ERP (ms)
HRA 187 6 3 190 6 3 NS
RPL 197 6 4 200 6 5 NS
DCS 203 6 5 196 6 4 NS
Dispersion 31 6 3 22 6 2 ,0.05
Threshold (mV)
HRA 0.78 6 0.05 0.72 6 0.04 NS
RPL 0.72 6 0.05 0.70 6 0.04 NS
DCS 0.90 6 0.07 0.88 6 0.05 NS
DCS 5 distal coronary sinus, ERP 5 effective refractory period, HRA 5
high right atrium, LAA/RAA 5 left/right atrial area, MRAP 5 mean right atrial
pressure, MBP 5 mean blood pressure, PCWP 5 pulmonary capillary wedge
pressure.
Table 2. Hemodynamics, Atrial Size, Electrophysiologic
Characteristics During PSVT
Group I II p value
MBP (mm Hg) 95 6 3 98 6 3 NS
MRAP (mm Hg) 8.2 6 0.7 7.5 6 0.8 NS
PCWP (mm Hg) 21.6 6 1.2 18.5 6 1.0 NS
RAA (cm2) 13.6 6 0.5 13.1 6 0.5 NS
LAA (cm2) 13.8 6 0.6 13.2 6 0.6 NS
ERP (ms)
HRA 189 6 4 194 6 4 NS
RPL 222 6 5 213 6 4 NS
DCS 217 6 4 209 6 4 NS
Dispersion 47 6 3 31 6 2 ,0.0001
Threshold (mV)
HRA 0.66 6 0.05 0.64 6 0.04 NS
RPL 0.63 6 0.03 0.61 6 0.03 NS
DCS 0.75 6 0.05 0.77 6 0.04 NS
DCS 5 distal coronary sinus, ERP 5 effective refractory period, HRA 5
high right atrium, LAA/RAA 5 left/right atrial area, MRAP 5 mean right atrial
pressure, MBP 5 mean blood pressure, PCWP 5 pulmonary capillary wedge
pressure, PSVT 5 paroxysmal supraventricular tachycardia.
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vs 0.77 6 0.04 mV, p , 0.05) were lower during PSVT whereas
AERP dispersion was greater during PSVT (Fig. 3). Further-
more, atrial vulnerability was higher during PSVT (22 of 50, 44%)
than during baseline study (7 of 50, 12%, p , 0.005).
Analysis of all the measured parameters showed that Group
I patients had greater difference of atrial size (left and right),
AERP in the right posterolateral atrium, and AERP dispersion
between baseline study and PSVT than Group II patients
(Figs. 1–3).
Parameters of autonomic nervous system. As shown in
Figure 4, the BRS was significantly higher in Group I than in
Group II (6.3 6 0.3 versus 3.3 6 0.2, p , 0.000001); further-
more, the incidence of PAF was significantly higher in patients
with a BRS more than 4.5 ms/mm Hg than those with a BRS
less than 4.5 ms/mm Hg (78% versus 19%, p , 0.05). Analysis
of the 24-h heart rate variability showed that all the parameters
were similar between Group I and Group II (Table 3).
Determinants of PAF. Univariate logistic regression anal-
ysis showed that higher BRS (.4.5 ms/mm Hg, p 5 0.0002,
odds ratio 5 16.1), AERP dispersion during PSVT (.40 ms,
p 5 0.0008, odds ratio 5 9.7), and increase of right atrial area
during PSVT (.2 cm2, p 5 0.016, odds ratio 5 10.7) were
significantly correlated with the occurrence of PAF, whereas
Figure 1. The differences of left atrial area (LAA) or right atrial area
(RAA) between baseline study and PSVT in Group I and Group II.
*p , 0.05, PSVT versus baseline study.
Figure 2. The differences of effective refractory periods (ERP) in the
high right atrium (HRA), right posterolateral atrium (RPL) and distal
coronary sinus (DCS) between baseline study and PSVT in Group I
and Group II. *p , 0.05, PSVT versus baseline study.
Figure 3. The differences of AERP dispersion between baseline study
and PSVT in Group I and Group II. *p , 0.05, PSVT versus baseline
study.
Figure 4. Plot of individual values of BRS in Group I and Group II.
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higher BRS was associated with the highest odds ratio. The
other factors including age, tachycardia cycle length, heart rate
variability and other hemodynamic parameters did not corre-
late with the occurrence of PAF. Furthermore, multivariate
analysis could not find any independent factor correlated with
the occurrence of PAF.
Discussion
Main findings. This study demonstrated that AERP dis-
persion was increased as the atrial pressure was elevated
during PSVT and the patients who were associated with PAF
had greater AERP dispersion and greater increase of atrial
size during PSVT. Moreover, the patients who were associated
with PAF had a higher BRS than those without PAF. Univar-
iate analysis showed that BRS was the most powerful deter-
minants of the occurrence of PAF.
Role of atrial electrophysiologic characteristics. Atrial re-
fractoriness and dispersion. Electrophysiologic characteristics of
atrium have been considered to play an important role in the
genesis of AF in patients with PSVT (1,5,6,12). In this study,
we evaluated AERPs in three atrial sites, and found no
significant difference between patients with and without PAF
during baseline study and PSVT. Della Bella et al. (6) also
showed that atrial refractoriness was not different between
patients with and without a history of PAF. However, Fujimura
et al. (5) demonstrated a shorter atrial functional refractory
period in patients who had Wolff-Parkinson-White syndrome
with PAF.
It has been demonstrated that an increase of atrial pressure
would result in a significant prolongation of monophasic action
potential duration at 90% repolarization and produce atrial
arrhythmias (20). Klein et al. (13) have indicated that high
right AERP was increased during PSVT (both in AV reentrant
tachycardia and AV nodal reentrant tachycardia) and during
pacing at certain AV interval. In this study, an increase of atrial
pressure during PSVT did increase AERPs in the right pos-
terolateral atrium and distal coronary sinus; however, high
right lateral AERP was not significantly changed during PSVT.
Calkins et al. (21) also reported a similar result that high right
lateral atrial AERP did not change during different atrial
pressure caused by alterations in the AV interval. The electro-
physiologic basis for the different changes of effective refrac-
tory periods among different atrial sites was not clear. Satoh et
al. (14) have demonstrated that atrium was stretched unequally
during increasing atrial pressure, which would result in an
unequal prolongation of refractoriness between crista termi-
nalis and right atrial free wall in canine hearts. In this study,
the effects of increasing atrial pressure on atrial refractoriness
were different among different atrial sites, which may arise
from the effect of heterogeneous atrial tissue characteristics, or
an unequal distribution of autonomic innervation in human
atrium (22,23). In addition, this study showed that patients
with PAF had a greater increase of right posterolateral AERP
during PSVT than those without PAF. It is possible that the
greater increase of right posterolateral AERP results in
greater AERP dispersion in patients with PAF.
Moe et al. (24,25) have demonstrated that dispersion of atrial
refractory period was a key factor for initiation of atrial arrhyth-
mia. Misier et al. (26) found that patients with idiopathic AF had
more atrial dispersion of refractoriness than patients without AF.
Moreover, experimental observations also suggested that AERP
dispersion was important in determining the ability to sustain AF,
which was significantly affected by vagal activity (27,28). This
study showed that AERP dispersion during baseline study was
greater in patients with PAF than in those without PAF. More-
over, the greatest AERP dispersion was found during PSVT in
patients with PAF. These findings suggested that the significant
increase of AERP dispersion may create more heterogenous
conduction, which would favor the induction and maintenance of
PAF. Thus, the increase of AERP dispersion during PSVT in this
study might suggest that PAF was more likely to originate from
degeneration of PSVT rather than de novo as another primary
arrhythmia (2).
Atrial vulnerability. Several investigators have demon-
strated the role of atrial vulnerability in the occurrence of PAF
(1,6,12). Della Bella et al. (6) have demonstrated that a single
atrial extrastimulus could induce PAF more easily in patients
with a history of PAF than in those without a history of PAF.
However, these studies did not evaluate the difference of atrial
vulnerability between baseline and PSVT. In this study, during
baseline study and PSVT, AF was induced more easily in
patients with a history of PAF than those without a history of
PAF. Furthermore, our results showed that AF was induced
more frequently during PSVT than during baseline study.
These findings suggested that increased atrial vulnerability
during PSVT could be a trigger factor of AF.
Role of tachycardia cycle length. Cycle length of AV
reentrant tachycardia has been considered to be shorter in
patients with a history of PAF than in those without a history
of PAF (7). On the contrary, both Della Bella et al. (6) and
Fujimura et al. (5) showed that the occurrence of PAF in AV
reentrant tachycardia was not related to the cycle length of
tachycardia. Hamer et al. (4) also showed that the occurrence
of PAF was not related to the rate of PSVT. In this study, the
tachycardia cycle length was similar between patients with and
without PAF.
Table 3. Heart Rate Variability in Group I and Group II
I II p value
Mean RR interval 821 6 35 747 6 35 NS
SDNN (ms) 152 6 13 123 6 12 NS
rMSSD (ms) 60 6 21 53 6 13 NS
PNN50 6.6 6 1.5 5.5 6 1.5 NS
LF (ms2) 535 6 112 423 6 90 NS
HF (ms2) 263 6 37 216 6 55 NS
LF/HF 2.5 6 0.4 3.1 6 0.8 NS
HF/LF 5 high/low frequency area of power spectral analysis; rMSSD 5 the
root mean square of differences of successive RR intervals; PNN50 5 the
percentage of adjacent RR intervals that differed by more than 50 ms; SDNN 5
standard deviation of NN intervals.
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Role of atrial size and atrial pressure. Previous study has
shown that a critical mass of atrial tissue was necessary to
produce AF (17,29). Although this study showed that the atrial
size was similar between patients with and without PAF during
baseline study and PSVT, the patients with PAF had greater
difference of atrial size between baseline study and PSVT than
those without PAF. Thus, an acute increase of atrial size in
these patients may provide more wavelets for the sustenance of
AF. Moreover, PAF could arise from enhancement of vagal
activity caused by acute increase of atrial size (30,31).
Role of autonomic nervous system. Autonomic nervous
system was proposed to be involved in the genesis of AF.
Coumel et al. (16) have demonstrated that some cases of lone
AF were associated with periods of enhanced vagal tone.
However, the role of autonomic nervous system in the occur-
rence of PAF in patients with PSVT has not been evaluated.
It has been demonstrated that increase of atrial pressure
during tachycardia can activate cardiac mechanoreceptors
and lead to an enhancement of vagal activity (30,31). In
addition, it is known that tachycardia generally causes a fall
of blood pressure at their onset and progressive elevation of
blood pressure is followed with increase of vagal activity
(32). Furthermore, previous studies have shown that admin-
istration of acetylcholine or methylcholine to the atrium
could induce AF, and vagal stimulation could induce pro-
longed episodes of AF (33,34). In this study, patients who
had PSVT associated with PAF had a better BRS than
patients without PAF. Besides, univariate regression showed
that BRS was the most correlated with the occurrence of
PAF in patients with PSVT. Although we could not evaluate
dynamic vagal activity directly using nerve recording during
PSVT, it is possible that patients with a better BRS have
higher vagal activity during the tachycardia.
Although this study showed that a BRS test (measures of
autonomic reflex modulation) was correlated well with the
occurrence of PAF, the study found no difference in the
measurement of heart rate variability, including time domain
measures and power spectral measures between patients with
and without PAF. Analysis of heart rate variability has been
used as a noninvasive index of parasympathetic tone and
sympathovagal balance (35,36). The absence of any difference
in these variables suggested that the tonic modulation in
baseline conditions did not provide information on the occur-
rence of PAF in patients with PSVT.
Conclusions. This study demonstrated the importance of
abnormal atrial electrophysiology in the genesis of PAF in
patients with PSVT; furthermore, a higher BRS was closely
related to the occurrence of PAF in PSVT.
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